Key result
High estimated pulse wave velocity (>11.355 m/s) was significantly associated with an increased risk of 28-day mortality (HR 1.87) compared to low ePWV in patients with AKI and congestive heart failure.
Why the study?
Although ePWV predicts mortality in AKI and HF individually, its relationship with 28-day mortality in patients with combined AKI and CHF remained to be explored.
Is high estimated pulse wave velocity associated with increased 28-day mortality in patients with acute kidney injury combined with congestive heart failure?
Cohort (n=12,119)
No
Is high estimated pulse wave velocity associated with increased 28-day mortality in patients with acute kidney injury combined with congestive heart failure?
Hazard Ratio: 1.87 (95% CI 1.68–2.08)
Absolute Event Rate: 24.29% vs 13.65%
p-value: p=<0.001
Estimated pulse wave velocity is a significant, independent predictor of 28-day mortality in patients with concurrent acute kidney injury and congestive heart failure.
Background Estimated pulse wave velocity (ePWV) is considered a standalone predictor of mortality in acute kidney injury (AKI) patients throughout their hospitalization. As ePWV increases, the all-cause mortality of heart failure patients increases. This research aimed to explore the connection between ePWV and 28-day mortality among patients diagnosed with AKI alongside congestive heart failure (CHF).Methods This study includes 12,119 patients with AKI combined with CHF from the MIMIC-IV database. The ePWV was categorized into a high group (>11.355 m/s) and a low group (≤11.355 m/s) based on the ROC curve cutoff value. To elucidate the discrepancy of survival outcomes between the groups, a Kaplan-Meier survival analysis was conducted. Cox proportional hazards regression models were used to analyze the interplay between ePWV and the risk of mortality within 28 days for the patients. To delve into the dose-response relationship, restricted cubic spline (RCS) model was employed. Stratified analyses were carried out to assess the influence of varying ePWV levels on 28-day mortality across diverse subpopulations.Results Survival analysis reveals that patients exhibiting high ePWV demonstrate a significantly reduced survival rate of 28-day in comparison to those with low ePWV. Moreover, after adjusting for covariates, a strong correlation exists between high ePWV and an increased risk of mortality within 28 days (HR = 1.87,95% CI = 1.68–2.08, p < 0.001). The RCS curve shows a linear increase in 28-day mortality with increasing ePWV levels (p for nonlinearity = 0.224).Conclusion ePWV was significantly associated with 28-day risk of death in patients with AKI-CHF and was a standalone forecasting factor of it.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a cohort in Acute kidney injury combined with congestive heart failure (n=12,119). High estimated pulse wave velocity (>11.355 m/s) vs. Low estimated pulse wave velocity (≤11.355 m/s) was evaluated on 28-day mortality (HR 1.87, 95% CI 1.68-2.08, p=<0.001). High estimated pulse wave velocity (>11.355 m/s) was significantly associated with an increased risk of 28-day mortality (HR 1.87) compared to low ePWV in patients with AKI and congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: